Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. James Healthcare Cancer Care
mi
from
Butte, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. James Healthcare Cancer Care
mi
from
Butte, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Big Sky Oncology
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Big Sky Oncology
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Clinical Research Facility
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. Peter's Hospital
mi
from
Helena, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Community Medical Center
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Community Medical Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Montana Cancer Center
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Good Samaritan Cancer Center at Good Samaritan Hospital
mi
from
Kearney, NE
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Good Samaritan Cancer Center at Good Samaritan Hospital
mi
from
Kearney, NE
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Kinston Medical Specialists
mi
from
Kinston, NC
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Barberton Citizens Hospital
mi
from
Barberton, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Barberton Citizens Hospital
mi
from
Barberton, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Cancer Care Center, Incorporated
mi
from
Salem, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Cancer Care Center, Incorporated
mi
from
Salem, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Cancer Treatment Center
mi
from
Wooster, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
McLeod Regional Medical Center
mi
from
Florence, SC
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
McLeod Regional Medical Center
mi
from
Florence, SC
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
CCOP - Greenville
mi
from
Greenville, SC
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Medical City Dallas Hospital
mi
from
Dallas, TX
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Medical City Dallas Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Click here to add this to my saved trials
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
A Phase II Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Status: Enrolling
Updated:  2/23/2016
Lalita Pandit, MD, Inc.
mi
from
Fountain Valley, CA
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
A Phase II Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Status: Enrolling
Updated: 2/23/2016
Lalita Pandit, MD, Inc.
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Status: Enrolling
Updated:  2/24/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Status: Enrolling
Updated: 2/24/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin
Status: Enrolling
Updated:  2/25/2016
Hunter Holmes McGuire Veterans Administration Medical Center
mi
from
Richmond, VA
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin
Status: Enrolling
Updated: 2/25/2016
Hunter Holmes McGuire Veterans Administration Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin
Status: Enrolling
Updated:  2/25/2016
Southside Regional Medical Center
mi
from
Richmond, VA
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin
Status: Enrolling
Updated: 2/25/2016
Southside Regional Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin
Status: Enrolling
Updated:  2/25/2016
Massey Cancer Center, Virginia Commonwealth University
mi
from
Richmond, VA
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin
Status: Enrolling
Updated: 2/25/2016
Massey Cancer Center, Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated:  2/25/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated: 2/25/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated:  2/25/2016
Lahey Clinic - Burlington
mi
from
Burlington, MA
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated: 2/25/2016
Lahey Clinic - Burlington
mi
from
Burlington, MA
Click here to add this to my saved trials
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated:  2/25/2016
University of Massachusetts Memorial Medical Center - University Campus
mi
from
Worcester, MA
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated: 2/25/2016
University of Massachusetts Memorial Medical Center - University Campus
mi
from
Worcester, MA
Click here to add this to my saved trials
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated:  2/25/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment
Status: Enrolling
Updated: 2/25/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Multi-site Decision Impact Study for Decipher
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Status: Enrolling
Updated:  2/26/2016
Cedar Associates LLC
mi
from
Menlo Park, CA
Multi-site Decision Impact Study for Decipher
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Status: Enrolling
Updated: 2/26/2016
Cedar Associates LLC
mi
from
Menlo Park, CA
Click here to add this to my saved trials
Multi-site Decision Impact Study for Decipher
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Status: Enrolling
Updated:  2/26/2016
Florida Hospital
mi
from
Celebration, FL
Multi-site Decision Impact Study for Decipher
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Status: Enrolling
Updated: 2/26/2016
Florida Hospital
mi
from
Celebration, FL
Click here to add this to my saved trials
Multi-site Decision Impact Study for Decipher
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Status: Enrolling
Updated:  2/26/2016
Columbia University
mi
from
New York, NY
Multi-site Decision Impact Study for Decipher
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Status: Enrolling
Updated: 2/26/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Central Hematology/Oncology Medical Group, Inc.
mi
from
Alhambra, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Central Hematology/Oncology Medical Group, Inc.
mi
from
Alhambra, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Comprehensive Blood and Cancer Center
mi
from
Bakersfield, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Comprehensive Blood and Cancer Center
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Virginia K. Crosson Cancer Center
mi
from
Fullerton, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Virginia K. Crosson Cancer Center
mi
from
Fullerton, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Pacific Shores Medical Group
mi
from
Long Beach, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Pacific Shores Medical Group
mi
from
Long Beach, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
UCLA Medical Center
mi
from
Los Angeles, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
North Valley Hematology-Oncology Medical Group
mi
from
Northridge, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
North Valley Hematology-Oncology Medical Group
mi
from
Northridge, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Wilshire Oncology Medical Group, Inc.
mi
from
Pomona, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Wilshire Oncology Medical Group, Inc.
mi
from
Pomona, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Cancer Care Associates Medical Group, Inc.
mi
from
Redondo Beach, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Cancer Care Associates Medical Group, Inc.
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Sansum- Santa Barbara medical foundation Clinic
mi
from
Santa Barbara, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Sansum- Santa Barbara medical foundation Clinic
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Santa Barbara Hematology Oncology Medical Group, Inc.
mi
from
Santa Barbara, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Santa Barbara Hematology Oncology Medical Group, Inc.
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Central Coast Medical Oncology Corporation
mi
from
Santa Maria, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Central Coast Medical Oncology Corporation
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
San Diego Cancer Center
mi
from
Vista, CA
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
San Diego Cancer Center
mi
from
Vista, CA
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Cancer Institute Of Florida
mi
from
Orlando, FL
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Cancer Institute Of Florida
mi
from
Orlando, FL
Click here to add this to my saved trials